Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-11-29 | Future report Set alerts | |
Q2 2022 | 2022-09-07 | 0.39 | 0.39 |
Q1 2023 | 2022-09-01 | Future report Set alerts | |
Q4 2022 | 2022-03-17 | 0.98 | 0.98 |
Q1 2022 | 2021-06-07 | 0.53 | 0.53 |
Q4 2021 | 2021-03-18 | 0.30 | 0.30 |
Q3 2021 | 2020-12-08 | 1.29 | 1.29 |
Q2 2021 | 2020-09-09 | -0.31 | -0.31 |
Q1 2021 | 2020-06-04 | -0.75 | -0.75 |
Q4 2020 | 2020-03-19 | 0.75 | 0.75 |
2016-06-21 | Initiated Coverage | Brean Capital | Buy | $51.00 |
2016-06-15 | Reiterated Rating | Piper Jaffray | Buy | |
2016-06-15 | Reiterated Rating | Piper Jaffray Cos. | Buy | |
2016-06-02 | Lower Price Target | Piper Jaffray | $48.00 | |
2016-05-31 | Reiterated Rating | Piper Jaffray | Overweight | $51.00 |
2016-05-22 | Reiterated Rating | Cowen and Company | Buy | |
2016-05-12 | Reiterated Rating | Stephens | Buy | |
2016-05-02 | Reiterated Rating | Piper Jaffray | Overweight | $51.00 |
2016-03-23 | Lower Price Target | KeyBanc | Overweight | $70.00 to $64.00 |
2016-03-23 | Lower Price Target | Cowen and Company | Outperform | $62.00 to $55.00 |
2016-03-23 | Lower Price Target | Brean Capital | Buy | $65.00 to $55.00 |
2016-03-23 | Lower Price Target | Wunderlich | Buy | $62.00 to $52.00 |
2016-03-23 | Lower Price Target | Telsey Advisory Group | Outperform | $64.00 to $54.00 |
2016-03-23 | Lower Price Target | KeyCorp | Overweight | $70.00 to $64.00 |
2016-03-21 | Reiterated Rating | Piper Jaffray | Overweight | $54.00 to $58.00 |
2016-03-19 | Reiterated Rating | Stephens | Buy | |
2016-03-08 | Reiterated Rating | Cowen and Company | Buy | |
2016-02-02 | Reiterated Rating | Piper Jaffray | Overweight | $54.00 |
2016-01-13 | Reiterated Rating | Piper Jaffray | Overweight | $54.00 |
2016-01-05 | Upgrade | Telsey Advisory Group | Market Perform to Outperform | $64.00 |
2015-12-03 | Reiterated Rating | Brean Capital | Buy | $75.00 to $65.00 |
2015-12-02 | Reiterated Rating | Cowen and Company | Buy | $60.00 to $62.00 |
2015-12-02 | Reiterated Rating | Piper Jaffray | Overweight | $52.00 |
2015-11-25 | Lower Price Target | Wunderlich | Buy | $80.00 to $62.00 |
2015-11-25 | Lower Price Target | Telsey Advisory Group | Market Perform | $74.00 to $64.00 |
2015-11-12 | Reiterated Rating | Stephens | Buy | |
2015-11-11 | Reiterated Rating | Piper Jaffray | Buy | $70.00 to $52.00 |
2015-10-26 | Lower Price Target | KeyBanc | $79.00 to $75.00 | |
2015-10-26 | Reiterated Rating | Piper Jaffray | Overweight | $86.00 to $70.00 |
2015-10-08 | Reiterated Rating | Piper Jaffray | Buy | |
2015-09-28 | Reiterated Rating | Barclays | Overweight | $75.00 to $80.00 |
2015-09-28 | Reiterated Rating | Barclays PLC | Overweight | $75.00 to $80.00 |
2015-09-25 | Reiterated Rating | Brean Capital | Buy | $75.00 |
2015-09-03 | Reiterated Rating | Barclays | Overweight | $75.00 |
2015-09-03 | Reiterated Rating | Brean Capital | Buy | $75.00 |
2015-09-03 | Boost Price Target | Telsey Advisory Group | Outperform | $65.00 to $74.00 |
2015-09-02 | Reiterated Rating | Cowen and Company | Outperform | $71.00 to $75.00 |
2015-09-02 | Boost Price Target | Wunderlich | Buy | $75.00 to $80.00 |
2015-09-02 | Reiterated Rating | Piper Jaffray | Buy | $86.00 |
2015-08-28 | Reiterated Rating | Brean Capital | Buy | $75.00 |
2015-08-12 | Reiterated Rating | Piper Jaffray | Buy | $86.00 |
2015-08-12 | Upgrade | Brean Capital | Hold to Buy | $75.00 |
2015-08-04 | Initiated Coverage | Brean Capital | Hold | $75.00 |
2015-07-02 | Reiterated Rating | Barclays | Overweight | $75.00 |
2015-06-23 | Boost Price Target | Piper Jaffray | Overweight | $74.00 to $86.00 |
2015-06-05 | Reiterated Rating | KeyBanc | Overweight | $66.00 to $72.00 |
2015-06-03 | Reiterated Rating | Piper Jaffray | Overweight | $67.00 to $74.00 |
2015-06-03 | Boost Price Target | Barclays | Overweight | $65.00 to $75.00 |
2015-06-03 | Boost Price Target | Wunderlich | Buy | $62.00 to $75.00 |
2015-06-03 | Boost Price Target | Telsey Advisory Group | Market Perform | $58.50 to $65.00 |
2015-06-01 | Reiterated Rating | Cowen and Company | Outperform | $58.50 to $63.00 |
2015-05-05 | Reiterated Rating | Barclays | Overweight | $128.00 to $65.00 |
2015-03-25 | Boost Price Target | Stephens | Overweight | $54.00 to $61.00 |
2015-03-25 | Boost Price Target | Telsey Advisory Group | Market Perform | $56.50 to $58.50 |
2015-03-23 | Reiterated Rating | Wunderlich | Buy | $52.50 to $62.00 |
2015-01-15 | Set Price Target | Wunderlich | Buy | $52.50 |
2014-12-04 | Boost Price Target | Barclays | Overweight | $46.00 to $55.00 |
2014-12-04 | Boost Price Target | Cowen and Company | Outperform | $46.50 to $52.00 |
2014-12-04 | Initiated Coverage | Telsey Advisory Group | Market Perform | $45.00 to $50.00 |
2014-12-03 | Boost Price Target | Wunderlich | Buy | $50.00 to $52.50 |
2014-09-12 | Boost Price Target | Cowen and Company | $45.00 to $46.50 | |
2014-09-03 | Boost Price Target | Wunderlich | Buy | $46.00 to $50.00 |
2014-08-15 | Initiated Coverage | Wunderlich | Buy | $46.00 |
2014-07-17 | Boost Price Target | Cowen and Company | Outperform | $43.00 to $45.00 |
2014-06-27 | Reiterated Rating | Barclays | Overweight | $42.50 to $46.00 |
2014-06-04 | Boost Price Target | Telsey Advisory Group | Not Rated | $37.00 to $45.00 |
2014-06-04 | Boost Price Target | KeyBanc | $38.00 to $48.00 | |
2014-06-03 | Boost Price Target | Brean Capital | Buy | $42.50 to $45.50 |
2014-04-08 | Boost Price Target | Piper Jaffray | $40.00 to $42.50 | |
2014-04-02 | Boost Price Target | Cowen and Company | $37.50 to $40.00 | |
2014-03-18 | Initiated Coverage | Barclays | Overweight | $41.00 |
2013-12-05 | Boost Price Target | Telsey Advisory Group | Not Rated | $30.00 to $36.00 |
2013-11-04 | Downgrade | Sidoti | Buy to Neutral | |
2013-10-04 | Boost Price Target | Telsey Advisory Group | Not Rated | $29.00 to $30.00 |
2013-10-03 | Reiterated Rating | Barclays | Buy | $30.00 |
2013-10-03 | Boost Price Target | Brean Capital | Buy | $29.00 to $30.00 |
2012-08-23 | Downgrade | Standpoint Research | Buy to Hold | |
2012-05-09 | Upgrade | Standpoint Research | Hold to Buy | $36 |
2012-04-27 | Downgrade | Standpoint Research | Buy to Hold | |
2011-12-21 | Initiated | Standpoint Research | Buy | $34 |
2011-12-08 | Reiterated | Brean Murray | Buy | $28 to $31 |
2011-11-23 | Reiterated | Brean Murray | Buy | $35 to $28 |
2011-09-08 | Reiterated | Brean Murray | Buy | $45 to $35 |
2011-06-08 | Upgrade | KeyBanc Capital Mkts | Hold to Buy | $42 |
2016-06-21 | Initiated Coverage | Brean Capital | Buy | $51.00 |
2016-06-15 | Reiterated Rating | Piper Jaffray | Buy | |
2016-06-15 | Reiterated Rating | Piper Jaffray Cos. | Buy | |
2016-06-02 | Lower Price Target | Piper Jaffray | $48.00 | |
2016-05-31 | Reiterated Rating | Piper Jaffray | Overweight | $51.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In GIII 179 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Inc. | 7.64M |
Vanguard Group, Inc | 4.77M |
BlackRock Fund Advisors | 3.51M |
DIMENSIONAL FUND ADVISORS LP | 3.33M |
J. Goldman & Co LP | 1.84M |
STATE STREET CORP | 1.66M |
COOPER CREEK PARTNERS MANAGEMENT LLC | 1.41M |
ROYAL BANK OF CANADA | 1.32M |
BlackRock Institutional Trust Company, N.A. | 1.18M |
RS INVESTMENT MANAGEMENT CO LLC | 0.95M |
SCHWAB CHARLES INVESTMENT MANAGEMENT INC | 0.83M |
GEODE CAPITAL MANAGEMENT, LLC | 0.82M |
NOMURA HOLDINGS INC | 0.65M |
Invesco Ltd. | 0.63M |
Tributary Capital Management, LLC | 0.63M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
GOLDFARB MORRIS Chief Executive Officer | 10.12% (2266308) | CBK / GIII / LACO / OPY / RLJE / |
Aaron Sammy Vice Chairman | 0.98% (219952) | GIII / |
Goldfarb Jeffrey David Dir. of Business Develop. | 0.76% (169310) | GIII / |
MILLER WAYNE S Chief Operating Officer | 0.55% (122500) | GIII / |
KATZ CARL | 0.22% (49666) | GIII / |
NACKMAN NEAL Chief Financial Officer/Treas | 0.15% (34202) | GIII / |
WHITE RICHARD | 0.14% (30920) | ESCA / GIII / LACO / RGSE / |
VAN BOKHORST WILLEM | 0.12% (26207) | GIII / |
NOSTRA KATZ JEANETTE President | 0.06% (12777) | GIII / |
FELLER ALAN | 0.05% (10219) | GIII / |
VITALI CHERYL L | 0.04% (9507) | GIII / |
POMERANTZ LAURA H | 0.03% (7207) | GIII / ROIC / |
BROSIG THOMAS | 0.03% (6407) | GFF / GIII / |
SIRKIN ALLEN E | 0.02% (5207) | GIII / |